טוען...
The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up
Abstract. The combination of a vascular endothelial growth factor receptor antagonist, Sugen 5416 (SU5416), and chronic hypoxia is known to cause pronounced pulmonary hypertension (PH) with angioobliterative lesions in rats and leads to exaggerated PH in mice as well. We sought to determine whether...
שמור ב:
| הוצא לאור ב: | Pulm Circ |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
University of Chicago Press
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4278622/ https://ncbi.nlm.nih.gov/pubmed/25610598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/678508 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|